U.S. RETRACTABLE NEEDLE SAFETY SYRINGES MARKET ANALYSIS

U.S. Retractable Needle Safety Syringes Market, By Product Type (Manual, Automated), By End User (Hospitals, Physician Offices, Nursing Home, Dental Laboratories, Diagnostic Centers, Ambulatory Surgical Centers, Homecare Settings, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Store, E-Commerce)

U.S. Retractable Needle Safety Syringes Market: Key Developments

Retractable Technologies Inc., a company offers safety syringes featuring automated retraction technology, reported total net sales of US$44.7 million with an operating profit of US$9.7 million for the same time in 2018, compared to total net sales of US$11.0 million with an operating loss of US$ 2.7 million for the first quarter of 2023.
On February 16, 2023, Zephyrus Innovations (Zephyrus), a medical device company, announced that it has received its first product 510(k) Marketing Approval from the U.S. Food and Drug Administration (FDA) for its Aeroject 3ml safety syringe. Zephyrus Aeroject is a single-use auto-retractable syringe developed for easy one-handed injection.